Evidence map›Paper›PMID 40028658›Full record

ReviewFEBS letters2025

The multiple roles of the NlpC_P60 peptidase family in mycobacteria - an underexplored target for antimicrobial drug discovery.

Catharina Dos Santos Silva, Marcio Vinicius Bertacine Dias

Abstract readReview
In one paragraph

Review in FEBS letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Catharina Dos Santos SilvaDepartment of Microbiology, Institute of Biological Sciences, University of São Paulo, Brazil.ORCID https://orcid.org/0000-0002-4171-6254
Marcio Vinicius Bertacine DiasDepartment of Microbiology, Institute of Biological Sciences, University of São Paulo, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 151725/2022-5Conselho Nacional de Desenvolvimento Científico e Tecnológico 308223/2023-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/18721-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/03850-9Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/10577-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/12234-5Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/02235-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/15878-6
6 · The paper itself

Abstract

The main function of the cell wall is to maintain cellular integrity throughout the cell cycle by keeping the cell shape during growth and division. However, far from being a static structure, the cell wall undergoes constant recycling and even molecular modifications of its components. The major component of the bacterial cell wall is the peptidoglycan layer. The balance between peptidoglycan synthesis and degradation is crucial for cell viability and proliferation. Hence, factors involved in the control of peptidoglycan turnover are considered interesting targets for drug development. Members of the NlpC_P60 superfamily of peptidases have been described to participate in the physiology and pathogenesis of several bacterial lineages. However, the knowledge about NlpC_P60-like proteins from mycobacteria is still limited, despite the great progress in recent years. In this Review, we aimed to compile the information about mycobacterial NlpC_P60 proteins, pointing out their distribution across pathogenic and environmental Mycobacterium species, highlighting the knowledge gaps and describing their structural features, role in the physiology and mycobacterial pathogenesis.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsDrug DiscoveryMycobacteriumPeptide HydrolasesCell WallHumansPeptidoglycanAnti-Bacterial AgentsBacterial ProteinsPeptide HydrolasesPeptidoglycancell divisioncysteine proteaseMycobacterium tuberculosispathogenesispeptidoglycan

Identifiers

PMID40028658
PMCPMC12067865

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.